查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1949619

胎兒監護市場 - 全球產業規模、佔有率、趨勢、機會及預測（按產品、行動裝置、性別、方法、應用、最終用戶、地區和競爭格局分類，2021-2031 年）

Fetal Monitoring Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Product, By Portability, By Method, By Application, By End User, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 181 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球胎兒監護市場預計將從 2025 年的 61.6 億美元成長到 2031 年的 92.5 億美元，複合年成長率為 7.01%。

此領域著重於持續評估胎兒生命徵象，例如心率和子宮收縮，以保障懷孕和分娩期間的健康。早產和高風險懷孕率的上升是推動該領域發展的主要因素，這些情況需要更密切的監測以確保安全。此外，全球孕婦人口老化也增加了對孕婦進行嚴密監測以應對併發症和降低死亡風險的必要性。例如，美國早產兒基金會（March of Dimes）的一份報告預測，到2024年，美國的早產率將維持在令人擔憂的10.4%，這凸顯了持續運用這些診斷工具應對孕產婦健康挑戰的必要性。

市場概覽
預測期 2027-2031
市場規模：2025年 61.6億美元
市場規模：2031年 92.5億美元
複合年成長率：2026-2031年 7.01%
成長最快的細分市場 交付前
最大的市場 北美洲

儘管存在這些市場促進因素，但由於醫療級系統的購買和維護成本高昂，市場發展仍面臨重大障礙。這種經濟負擔限制了小規模診所和低收入地區採用必要的設備，阻礙了市場的廣泛普及。此外，正確分析監測數據所需的專業培訓也造成了營運瓶頸。更複雜的是，全球範圍內熟練的醫護人員短缺，阻礙了這些重要安全通訊協定在標準臨床環境中的廣泛應用。

市場促進因素

非侵入性攜帶式監測技術的突破性進展正推動市場顯著成長，使持續胎兒監測不再局限於傳統的醫院環境。這些無線設備無需將患者束縛在床邊設備即可監測生命徵象，從而增強了遠端系統管理能力，並提高了患者對護理計劃的依從性。這些技術進步使得在無需長期住院的情況下，能夠及時識別高風險妊娠的併發症，有效平衡了臨床安全性和患者自主性。例如，GE醫療的Novii+解決方案於2024年2月獲得FDA核准，將無線監測的選擇範圍擴大到更廣泛的患者群體。這項快速創新得益於強大的資金支持；矽谷銀行報告稱，2024年女性健康領域的創業投資投資將達到26億美元，為先進診斷工具的開發提供了關鍵資金。

此外，政府對孕產婦和嬰兒健康的支持是推動成長的關鍵因素，這主要體現在為產科基礎設施現代化提供資金方面。公共衛生機構優先考慮降低死亡率和消除醫療保健差距，並推動在農村和醫療服務不足地區推廣使用醫療設備。這些措施通常會補貼先進醫療設備的費用，同時強制執行嚴格的安全標準，以確保公平地獲得周產期保健服務。例如，2024年10月，美國衛生資源與服務管理局向旨在改善孕產婦健康和提高服務可近性的州級計劃津貼約1,900萬美元。此類專項公共資金降低了醫療中心的經濟負擔，並促進了必要胎兒評估技術的廣泛應用。

市場挑戰

全球胎兒監護市場發展的主要障礙在於對專業培訓的需求以及全球熟練醫務人員的短缺。胎兒監護設備會產生複雜的生理數據，例如子宮收縮和胎心率。正確分析這些數據需要高階臨床知識。如果無法準確區分無害的波動和真正的胎兒窘迫，可能會導致嚴重的健康風險，並為醫療機構帶來重大的法律風險。這種對專家解讀的依賴造成了瓶頸，能夠操作和解讀這些診斷工具的人員數量有限，從而限制了其應用。

因此，合格助產士和婦產科醫師的短缺直接限制了監測服務的擴展，尤其是在嚴重短缺的地區。許多醫療機構由於缺乏足夠的人員來維持嚴格的監測通訊協定，被迫限制採用先進的監測系統。根據美國婦產科醫師學會預測，到2025年，美國婦產科醫師的供應量將僅能滿足93.4%的需求。臨床需求與勞動力供應之間日益擴大的差距阻礙了這些重要安全措施的普遍應用，從而有效地抑制了市場成長。

市場趨勢

將人工智慧 (AI) 應用於預測性胎兒分析正在改變市場格局，使重點從基礎數據記錄轉向即時風險評估。現代演算法能夠分析複雜的心率模式，更早檢測出異常胎兒訊號，從而為早產和高風險懷孕的臨床決策提供支援。監管方面的成就也凸顯了這一發展趨勢，證實了人工智慧在將監測範圍擴展到懷孕更脆弱階段的效用。例如，PeriGen 的 Patterns 3.0 軟體於 2025 年 2 月獲得 FDA核准，將人工智慧驅動的模式識別擴展到妊娠 32 週的胎兒。這些創新使醫療團隊能夠更準確地處理嚴重病例，並減少對主觀分析的依賴，而主觀分析常常會導致急診護理的延誤。

同時，智慧型手機連接的智慧監測工具的興起推動了產前護理服務的去中心化，使孕婦能夠在家中進行臨床級別的檢測。這些攜帶式裝置可直接與行動應用程式連接，並將影像和資料傳輸給醫療服務提供者進行遠端評估，從而顯著減少了就醫次數。 2025年11月，Parsenmore公司獲得FDA的全新上市許可，進一步強化了這種以消費者為主導的連線健診醫療模式。該公司基於家庭的產前超音波平台使用智慧型手機底座，使患者能夠自行進行掃描。這項功能彌合了患者與產科醫生之間的地域差距，並提供持續的診斷級資訊流，有效解決了服務不足地區的醫療問題。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球胎兒監護市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依產品分類（超音波設備、設備、胎兒分娩監視器、子宮收縮監測儀、胎兒電極、胎兒多普勒設備、遙測設備、配件及耗材、其他）
    • 便攜性（可攜式系統和非可攜式系統）
    • 按方法（侵入性/非侵入性）
    • 使用方式（交付前、交付期間）
    • 依最終使用者（醫院、婦產科診所、居家醫療環境）分類
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章 北美胎兒監護市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

7. 歐洲胎兒監護市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

8. 亞太地區胎兒監護市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

9. 中東和非洲胎兒監護市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲胎兒監護市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進要素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章 全球胎兒照護市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的可能性
  • 供應商電力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Medtronic Plc
  • Cardinal Health Inc.
  • Koninklijke Philips NV
  • Siemens Healthineers AG
  • GE Healthcare Technologies Inc.
  • FUJIFILM SonoSite, Inc
  • Natus Medical Incorporated
  • Huntleigh Healthcare Limited
  • CooperCompanies Inc.
  • CONTEC Medical Systems Co., Ltd

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 14962

The Global Fetal Monitoring Market is projected to expand from USD 6.16 Billion in 2025 to USD 9.25 Billion by 2031, reflecting a compound annual growth rate of 7.01%. This sector focuses on the continuous evaluation of fetal vital signs, such as heart rates and uterine contractions, to safeguard health during pregnancy and labor. Growth is largely fueled by the rising incidence of preterm births and high-risk pregnancies, which demand intense surveillance to ensure safety. Furthermore, increasing maternal age globally has heightened the necessity for careful monitoring to handle complications and reduce mortality risks. For example, the March of Dimes reported that the preterm birth rate in the United States held steady at a worrying 10.4% in 2024, underscoring the ongoing need for these diagnostic tools to tackle maternal health challenges.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 6.16 Billion
Market Size 2031USD 9.25 Billion
CAGR 2026-20317.01%
Fastest Growing SegmentAntepartum
Largest MarketNorth America

Despite these drivers, market progress faces significant hurdles due to the high costs involved in purchasing and maintaining medical-grade systems. This financial burden restricts the deployment of essential equipment in smaller clinics and lower-income areas, thereby limiting broader market penetration. Moreover, the need for specialized training to correctly analyze monitoring data creates operational bottlenecks. A global scarcity of skilled healthcare practitioners further complicates matters, preventing the widespread application of these critical safety protocols in standard medical practice.

Market Driver

The market is being significantly propelled by breakthroughs in non-invasive and portable monitoring technologies, which allow for continuous fetal observation beyond the confines of traditional hospitals. These wireless devices monitor vital signs without keeping patients tethered to bedside machines, enhancing remote management capabilities and improving adherence to care plans. Such technological evolution permits the timely identification of complications in high-risk pregnancies without necessitating extended hospital stays, effectively balancing clinical safety with patient freedom. Illustrating this trend, GE HealthCare received FDA clearance in February 2024 for its Novii+ solution, expanding wireless monitoring options for a wider demographic. This rapid innovation is supported by strong financial backing; Silicon Valley Bank reported that venture capital investment in women's health hit $2.6 billion in 2024, providing crucial capital for developing these advanced diagnostic tools.

Furthermore, government support for maternal and infant health serves as a vital engine for growth by directing funds toward modernizing obstetric infrastructure. Public health bodies are prioritizing spending to lower mortality rates and close healthcare gaps, facilitating the purchase of medical-grade equipment in rural and underserved communities. These initiatives often subsidize the expense of sophisticated devices while enforcing strict safety standards to guarantee fair access to perinatal services. For instance, in October 2024, the Health Resources and Services Administration granted approximately $19 million to state-level projects designed to improve maternal health results and service availability. Such targeted public funding reduces economic obstacles for medical centers, encouraging the widespread adoption of necessary fetal assessment technologies.

Market Challenge

A major obstacle hindering the Global Fetal Monitoring Market is the necessity for specialized training alongside a worldwide lack of skilled healthcare workers. Fetal monitoring devices produce intricate physiological data, such as uterine contractions and fetal heart rate rhythms, which require high-level clinical knowledge for proper analysis. Failing to accurately differentiate between harmless variations and actual fetal distress can result in serious health consequences and substantial legal risks for healthcare providers. This reliance on expert interpretation generates a bottleneck, as the rollout of these diagnostic tools is limited by the availability of personnel capable of operating them and interpreting the results.

Consequently, the shortage of qualified midwives and obstetricians directly limits the ability to scale monitoring services, especially in areas with severe workforce shortages. Many medical institutions are compelled to restrict the implementation of advanced monitoring systems because they lack adequate staff to uphold rigorous surveillance protocols. According to the American College of Obstetricians and Gynecologists, the supply of obstetrician-gynecologists in the United States satisfied only 93.4% of the demand in 2025. This expanding disparity between clinical needs and workforce availability impedes the universal application of these vital safety measures, effectively stalling the market's growth.

Market Trends

The incorporation of Artificial Intelligence (AI) into predictive fetal analytics is transforming the market, shifting focus from basic data recording to real-time risk assessment. Modern algorithms are capable of examining complex heart rate patterns to detect distress signals sooner, thereby aiding clinical decisions regarding preterm and high-risk pregnancies. This evolution is highlighted by regulatory achievements that confirm AI's utility in broadening surveillance to include more vulnerable stages of gestation. For example, PeriGen obtained FDA clearance in February 2025 for its Patterns 3.0 software, extending its AI-driven pattern recognition to fetuses as young as 32 weeks. These innovations enable medical teams to handle critical cases with higher accuracy, diminishing the dependence on subjective analysis that frequently causes delays in acute care environments.

In parallel, the rise of smartphone-integrated smart monitoring tools is decentralizing prenatal services, empowering expectant mothers to conduct clinical-quality checks from home. These portable devices connect directly with mobile apps to send images and data to healthcare providers for remote evaluation, significantly lowering the frequency of required clinic visits. This shift toward consumer-oriented, connected healthcare was reinforced when Pulsenmore received FDA De Novo marketing authorization in November 2025 for its home-based prenatal ultrasound platform, which uses a smartphone dock to facilitate patient-guided scanning. This functionality effectively tackles the issue of care deserts by bridging the geographical gap between patients and obstetricians while ensuring a consistent flow of diagnostic-grade information.

Key Market Players

  • Medtronic Plc
  • Cardinal Health Inc.
  • Koninklijke Philips N.V.
  • Siemens Healthineers AG
  • GE Healthcare Technologies Inc.
  • FUJIFILM SonoSite, Inc
  • Natus Medical Incorporated
  • Huntleigh Healthcare Limited
  • CooperCompanies Inc.
  • CONTEC Medical Systems Co., Ltd

Report Scope

In this report, the Global Fetal Monitoring Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Fetal Monitoring Market, By Product

  • Ultrasound
  • Device
  • Fetal Monitors
  • Uterine Contraction Monitors
  • Fetal Electrodes
  • Fetal Doppler Device
  • Telemetry Device
  • Accessories and Consumables
  • Others

Fetal Monitoring Market, By Portability

  • Portable System and Non-Portable System

Fetal Monitoring Market, By Method

  • Invasive and Non-invasive

Fetal Monitoring Market, By Application

  • Antepartum
  • Intrapartum

Fetal Monitoring Market, By End User

  • Hospitals
  • Obstetrics & Gynecology clinic
  • Home Care Setting

Fetal Monitoring Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Fetal Monitoring Market.

Available Customizations:

Global Fetal Monitoring Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Fetal Monitoring Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Ultrasound, Device, Fetal Monitors, Uterine Contraction Monitors, Fetal Electrodes, Fetal Doppler Device, Telemetry Device, Accessories and Consumables, Others)
    • 5.2.2. By Portability (Portable System and Non-Portable System)
    • 5.2.3. By Method (Invasive and Non-invasive)
    • 5.2.4. By Application (Antepartum, Intrapartum)
    • 5.2.5. By End User (Hospitals, Obstetrics & Gynecology clinic, Home Care Setting)
    • 5.2.6. By Region
    • 5.2.7. By Company (2025)
  • 5.3. Market Map

6. North America Fetal Monitoring Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Portability
    • 6.2.3. By Method
    • 6.2.4. By Application
    • 6.2.5. By End User
    • 6.2.6. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Fetal Monitoring Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Portability
        • 6.3.1.2.3. By Method
        • 6.3.1.2.4. By Application
        • 6.3.1.2.5. By End User
    • 6.3.2. Canada Fetal Monitoring Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Portability
        • 6.3.2.2.3. By Method
        • 6.3.2.2.4. By Application
        • 6.3.2.2.5. By End User
    • 6.3.3. Mexico Fetal Monitoring Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Portability
        • 6.3.3.2.3. By Method
        • 6.3.3.2.4. By Application
        • 6.3.3.2.5. By End User

7. Europe Fetal Monitoring Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Portability
    • 7.2.3. By Method
    • 7.2.4. By Application
    • 7.2.5. By End User
    • 7.2.6. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Fetal Monitoring Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Portability
        • 7.3.1.2.3. By Method
        • 7.3.1.2.4. By Application
        • 7.3.1.2.5. By End User
    • 7.3.2. France Fetal Monitoring Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Portability
        • 7.3.2.2.3. By Method
        • 7.3.2.2.4. By Application
        • 7.3.2.2.5. By End User
    • 7.3.3. United Kingdom Fetal Monitoring Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Portability
        • 7.3.3.2.3. By Method
        • 7.3.3.2.4. By Application
        • 7.3.3.2.5. By End User
    • 7.3.4. Italy Fetal Monitoring Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Portability
        • 7.3.4.2.3. By Method
        • 7.3.4.2.4. By Application
        • 7.3.4.2.5. By End User
    • 7.3.5. Spain Fetal Monitoring Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Portability
        • 7.3.5.2.3. By Method
        • 7.3.5.2.4. By Application
        • 7.3.5.2.5. By End User

8. Asia Pacific Fetal Monitoring Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Portability
    • 8.2.3. By Method
    • 8.2.4. By Application
    • 8.2.5. By End User
    • 8.2.6. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Fetal Monitoring Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Portability
        • 8.3.1.2.3. By Method
        • 8.3.1.2.4. By Application
        • 8.3.1.2.5. By End User
    • 8.3.2. India Fetal Monitoring Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Portability
        • 8.3.2.2.3. By Method
        • 8.3.2.2.4. By Application
        • 8.3.2.2.5. By End User
    • 8.3.3. Japan Fetal Monitoring Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Portability
        • 8.3.3.2.3. By Method
        • 8.3.3.2.4. By Application
        • 8.3.3.2.5. By End User
    • 8.3.4. South Korea Fetal Monitoring Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Portability
        • 8.3.4.2.3. By Method
        • 8.3.4.2.4. By Application
        • 8.3.4.2.5. By End User
    • 8.3.5. Australia Fetal Monitoring Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Portability
        • 8.3.5.2.3. By Method
        • 8.3.5.2.4. By Application
        • 8.3.5.2.5. By End User

9. Middle East & Africa Fetal Monitoring Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Portability
    • 9.2.3. By Method
    • 9.2.4. By Application
    • 9.2.5. By End User
    • 9.2.6. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Fetal Monitoring Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Portability
        • 9.3.1.2.3. By Method
        • 9.3.1.2.4. By Application
        • 9.3.1.2.5. By End User
    • 9.3.2. UAE Fetal Monitoring Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Portability
        • 9.3.2.2.3. By Method
        • 9.3.2.2.4. By Application
        • 9.3.2.2.5. By End User
    • 9.3.3. South Africa Fetal Monitoring Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Portability
        • 9.3.3.2.3. By Method
        • 9.3.3.2.4. By Application
        • 9.3.3.2.5. By End User

10. South America Fetal Monitoring Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Portability
    • 10.2.3. By Method
    • 10.2.4. By Application
    • 10.2.5. By End User
    • 10.2.6. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Fetal Monitoring Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Portability
        • 10.3.1.2.3. By Method
        • 10.3.1.2.4. By Application
        • 10.3.1.2.5. By End User
    • 10.3.2. Colombia Fetal Monitoring Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Portability
        • 10.3.2.2.3. By Method
        • 10.3.2.2.4. By Application
        • 10.3.2.2.5. By End User
    • 10.3.3. Argentina Fetal Monitoring Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Portability
        • 10.3.3.2.3. By Method
        • 10.3.3.2.4. By Application
        • 10.3.3.2.5. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Fetal Monitoring Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Medtronic Plc
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Cardinal Health Inc.
  • 15.3. Koninklijke Philips N.V.
  • 15.4. Siemens Healthineers AG
  • 15.5. GE Healthcare Technologies Inc.
  • 15.6. FUJIFILM SonoSite, Inc
  • 15.7. Natus Medical Incorporated
  • 15.8. Huntleigh Healthcare Limited
  • 15.9. CooperCompanies Inc.
  • 15.10. CONTEC Medical Systems Co., Ltd

16. Strategic Recommendations

17. About Us & Disclaimer